Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats

Nutrition

Volumn 28, Issue 5, 2012, Pages 572-580

  Bodiga, Vijaya Lakshmi ^a,b   Bodiga, Sreedhar ^a   Surampudi, Sreedhar ^b   Boindala, Sesikeran ^a   Putcha, Udaykumar ^a   Nagalla, Balakrishna ^a   Subramaniam, Kalyanasundaram ^a   Manchala, Raghunath ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b KRISHNA UNIVERSITY   (India)

Author keywords

Tocopherol; Chemotherapy; Cisplatin; Folate; Intestinal apoptosis; Oxidative stress; Riboflavin

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; CARBONYL DERIVATIVE; CASPASE 3; CISPLATIN; DIPEPTIDYL PEPTIDASE; FOLIC ACID; MULTIVITAMIN; PROTEIN BAX; PROTEIN BCL 2; RIBOFLAVIN; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; FOOD INTAKE; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE VILLUS; JEJUNUM; MALE; MONITORING; MORPHOMETRICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CISPLATIN; DIETARY SUPPLEMENTS; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; EPITHELIAL CELLS; FOLIC ACID; INTESTINES; OXIDATIVE STRESS; RATS; RATS, WISTAR; RIBOFLAVIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMINS;

RATTUS;

EID: 84859217023     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.09.007     Document Type: Article

References (63)

1. Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 1994, 269:787-790.
2. Yoshida M., Khokhar A.R., Siddik Z.H. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Cancer Res 1994, 54:3468-3473.
3. Harrison L.B., Pfister D.G., Fass D.E., Armstrong J.G., Sessions R.B., Shah J.P., et al. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991, 21:703-708.
4. Merrin C.E. Treatment of previously untreated (by hormonal manipulation) stage D adenocarcinoma of prostate with combined orchiectomy, estrogen, and cis diamminedichloroplatinum. Urology 1980, 15:123-126.
5. Smith I.E., Talbot D.C. Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br J Cancer 1992, 65:787-793.
6. Li G., Liu W., Frenz D. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS. Neurotoxicology 2006, 27:22-30.
7. Schwerdt G., Freudinger R., Schuster C., Weber F., Thews O., Gekle M. Cisplatin induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells. Toxicol Sci 2005, 85:735-742.
8. Low-Friedrich I., von Bredow F., Schoeppe W. In vitro studies on the cardiotoxicity of chemotherapeutics. Chemotherapy 1990, 36:416-421.
9. Berliner S., Rahima M., Sidi Y., Teplitsky Y., Zohar Y., Nussbaum B., et al. Acute coronary events following cisplatin-based chemotherapy. Cancer Invest 1990, 8:583-586.
10. Meyn R.E., Stephens L.C., Hunter N.R., Milas L. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer 1995, 60:725-729.
11. Sorenson C.M., Barry M.A., Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 1990, 82:749-755.
12. Vijayalakshmi B., Sesikeran B., Udaykumar P., Kalyanasundaram S., Raghunath M. Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats. World J Gastroenterol 2006, 12:1078-1085.
13. Arivarasu N.A., Fatima S., Mahmood R. Effect of cisplatin on brush border membrane enzymes and anti-oxidant system of rat intestine. Life Sci 2007, 81:393-398.
14. Mandic A., Hansson J., Linder S., Shoashan M.C. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 2003, 278:9100-9106.
15. Xue H., Sawyer M.B., Wischmeyer P.E., Baracos V.E. Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy from preclinical findings to clinical strategy. J Parenter Enteral Nutr 2011, 35:v174-v190.
16. Bowen G.M., Gibson R.J., Stringer A.M., Chan T.W., Prabowo A.S., Cummins A.G., et al. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage. Anticancer Drugs 2007, 18:197-210.
17. Leblond J., Le Pessot F., Hubert-Buron A., Duclos C., Vuichoud J., Faure M., et al. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood) 2008, 233:219-228.
18. Boukhettala N., Leblond J., Claeyssens S., Faure M., Le Pessot F., Bôle-Feysot C., et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab 2009, 296:E182-E190.
19. Conklin K.A. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000, 37:1-18.
20. Lamson D.W., Brignall M.S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999, 4:304-329.
21. Salganik R.I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and human population. J Am Coll Nutr 2001, 20:464S-472S.
22. Bodiga V.L., Boindala S., Putcha U., Subramaniam K., Manchala R. Chronic low intake of protein or vitamins increases the intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition 2005, 21:949-960.
23. Vijayalakshmi B., Sesikeran B., Udaykumar P., Kalyanasundaram S., Raghunath M. Effects of vitamin restriction and supplementation on rat intestinal epithelial cell apoptosis. Free Radic Biol Med 2005, 38:1614-1624.
24. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997, 94:3290-3295.
25. Duthie S.J., Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998, 12:1491-1497.
26. Shane B. Folate chemistry and metabolism. Folate in health and disease 1995, 1-22. Marcel Dekker, New York. L.B. Bailey (Ed.).
27. Choi S.W., Kim Y.I., Weitzel J.N., Mason J.B. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998, 43:93-99.
28. Choi S.W., Mason J.B. Folate and carcinogenesis: an integrated scheme. J Nutr 2000, 130:129-132.
29. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997, 24:S18-S39.
30. Rivlin R.S. Riboflavin. Present knowledge in nutrition 2001, 191-198. ILSI Press, Washington, DC. B.A. Bowman, R.M. Russell, B.A. Bowman, R.M. Russell (Eds.).
31. Manthey K.C., Chew Y.C., Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress-response systems. J Nutr 2005, 135:978-982.
32. Manthey K.C., Rodriguez-Melendez R., Hoi J.T., Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem 2006, 17:250-256.
33. Packer L., Weber S.U., Rimbach G. Molecular aspects of α-tocopherol antioxidant action and cell signaling. J Nutr 2001, 131:369-373.
34. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 Purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
35. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determinations in membrane and lipoprotein samples. Anal Biochem 1978, 87:206-210.
36. Rask C., Albertioni F., Bentzen S.M., Schroeder H., Peterson C. Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia-a logistic regression analysis. Acta Oncol 1998, 37:277-284.
37. Benard O., Madesh M., Anup R., Balasubramaniam K.A. Apoptotic process in the monkey small intestinal epithelium: I. Association with glutathione levels and its efflux. Free Radic Biol Med 1999, 26:245-252.
38. Stringer A.M., Gibson R.J., Bowen J.M., Logan R.M., Yeoh A.S., Keefe D.M. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. J Support Oncol 2007, 5:259-267.
39. Choi K., Lee S.S., Oh S.J., Lim S.Y., Jeon W.K., Oh T.Y., Kim J.W. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 2007, 26:57-62.
40. Smit J.M., Mulder N.H., Sleijfer D.T., Bouman J.G., Veeger W. Evaluation of gastrointestinal toxicity following cytostatic chemotherapy. J Cancer Res Clin Oncol 1986, 111:59-61.
41. Uday Kumar P., Vijayalakshmi B., Kalyanasundaram S., Raghunath M., Sesikeran B. Effect of varying doses of cisplatin on rat intestinal cell apoptosis. J Lab Anim Sci 2011, 1:43-48.
42. Weijl N.I., Leton F.J., Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 1997, 23:209-240.
43. Sangeetha P., Das U.N., Koratkar R., Suryaprabha P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990, 8:15-19.
44. Durken M., Agbenu J., Finckh B., Hübner C., Pichlmeier U., Zeller W., et al. Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant 1995, 15:757-762.
45. Lauterburg B.H., Nguyen T., Hartmann B., Junker E., Kupfer A., Cerny T. Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy. Cancer Chemother Pharmacol 1994, 35:132-136.
46. Clemens M.R., Ladner C., Schmidt H., Ehninger G., Einsele H., Bühler E., et al. Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. Free Radic Res Commun 1989, 7:227-232.
47. Johnson L.R. Regulation of gastrointestinal mucosal growth. Physiol Rev 1988, 68:456-502.
48. Potten C.S., Booth C. The role of radiation-induced and spontaneous apoptosis in homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol 1997, 118:473-478.
49. Aw T.W. Cellular redox: a modulator of intestinal epithelial cell proliferation. News Physiol Sci 2003, 18:201-204.
50. Fujimoto K., Iwakiri R., Wu B., Fujise T., Tsunada S., Ootani A. Homeostasis in the small intestinal mucosa balanced between cell proliferation and apoptosis is regulated partly by the central nervous system. J Gastroenterol 2002, 37:139-144.
51. Iwakiri R., Gotoh Y., Noda T., Sugihara H., Fujimoto K., Fuseler J., Aw T.Y. Programmed cell death in rat intestine: effect of feeding and fasting. Scand J Gastroenterol 2001, 36:39-47.
52. Ruemmele F.M., Russo P., Beaulieu J., Dionne S., Levy E., Lentze M.J., et al. Susceptibility to FAS-induced apoptosis in human non-tumoral enterocytes-the role of co-stimulatory factors. J Cell Physiol 1999, 181:45-54.
53. Strater J., Wellisch I., Riedl S., Walczak H., Koretz K., Tandara A., et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997, 113:160-167.
54. Moss S.F., Agarwal B., Arber N., Guan R.J., Krajewska M., Krajewski S., et al. Increased intestinal bak expression results in apoptosis. Biochem Biophys Res Commun 1996, 223:199-203.
55. Potten C.S. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 1992, 11:179-185.
56. Keefe D.M., Brealey J., Goland G.J., Cummins A.G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000, 47:632-637.
57. Bodiga S., Krishnapillai M.N. Modulation of aconitase, metallothionein, and oxidative stress in zinc-deficient rat intestine during zinc and iron repletion. Free Radic Biol Med 2005, 39:999-1008.
58. Legha S.S., Wang Y.M., Mackay B., Ewer M., Hortobagyi G.N., Benamin R.S., Ali M.K. Clinical and pharmacologic investigation of the effects of alpha-tocopherol on Adriamycin toxicity. Ann N Y Acad Sci 1982, 393:411-418.
59. Berthiaume J.M., Oliveira P.J., Fariss M.W., Wallace K.B. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol 2005, 5:257-267.
60. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., et al. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 1995, 55:354-359.
61. Wang J., Wei Q., Wang C.Y., Hill W.D., Hess D.C., Dong Z. Minocycline upregulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004, 279:19948-19954.
62. Schaaf G.J., Maas R.F., De Groene E.M., Fink-Gremmels J. Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic Res 2002, 36:835-843.
63. Hirano G., Izumi H., Yasuniwa Y., Shimajiri S., Ke-Yong W., Sasagiri Y., et al. Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin. Int J Oncol 2011, 38:893-902.